Trial Profile
Safety and efficacy of treprostinil in pulmonary arterial hypertension
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Jan 2016
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions; Therapeutic Use
- 13 Jan 2016 New trial record